Pharma & Biotech

Rockwell Medical's stock continues its relentless downward trajectory, with Friday's trading session delivering another devastating blow to shareholder value. The...

FibroGen's stock continued its downward trajectory on Friday, closing at $10.55 after declining 3.74% during the trading session. This latest...

Adicet Bio's stock demonstrated significant strength in Friday's trading session, climbing 5.80% to reach $0.97 per share. This upward movement...

Investors in IGC Pharma have delivered a powerful endorsement of the company's leadership and strategic direction. During yesterday's annual general...

The corporate identity of Allovir Inc. has been formally retired. A significant merger transaction with Kalaris Therapeutics, finalized in March...

Precision BioSciences Inc shares are demonstrating significant upward momentum, fueled by substantial advancements in its proprietary gene-editing platform. Recent scientific...

Swiss biopharmaceutical firm Idorsia Ltd has successfully concluded a capital increase that exceeded initial expectations, demonstrating robust market confidence. The...

Novo Nordisk is sending mixed signals to the market with a puzzling dual approach that has left investors questioning the...

Shares of Viking Therapeutics experienced significant upward momentum, climbing 8.1% to reach $33.90 amid renewed market speculation about potential acquisition...

The pharmaceutical giant Eli Lilly, headquartered in Indianapolis, is facing heightened investor scrutiny. A notable sell-off by key insiders has...